Safety, Tolerability, and Pharmacokinetics of Multiple Novel Insulin Lispro Formulations
Phase of Trial: Phase I
Latest Information Update: 11 Sep 2015
At a glance
- Drugs Insulin lispro (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 08 Sep 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 15 Jul 2015 According to the ClinicalTrials.gov record, planned number of patients changed from 48 to 81.
- 06 Jul 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.